Hikal Limited
Hikal Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: HIKAL and BSE: 524735 (ISIN INE475B01022).
It has a market capitalisation of ₹2,683 crore, a last close of ₹217.25 on 2026-10-19, a one-year return of -9.5%.
Valuation: a price-to-book ratio of 2.24x, a dividend yield of 0.3%.
Profitability: return on equity of -4.0%, return on capital employed of -0.9%, an operating margin of 13.4%.
Growth: sales growth of -5.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.57x, promoter holding of 68.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 2,683 |
| Last close | ₹217.25 |
| P/B | 2.24x |
| Dividend yield | 0.3% |
| ROE (FY) | -4.0% |
| ROCE (FY) | -0.9% |
| Operating margin (TTM) | 13.4% |
| Sales growth, 3-year CAGR | -5.4% |
| Debt / equity | 0.57x |
| Promoter holding | 68.9% |
| 1-year return | -9.5% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means